Otsuka buys commercialization rights to Lundbeck Alzhemier's disease drug

被引：0
|
作者：
Heseltine, Phoebe
机构：
来源：
FUTURE MEDICINAL CHEMISTRY | 2013年 / 5卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：863 / 863
页数：1
相关论文
共 50 条
  • [1] Otsuka buys commercialization rights to Lundbeck Alzhemier's drug
    Heseltine, Phoebe
    PHARMACEUTICAL PATENT ANALYST, 2013, 2 (03) : 300 - 300
  • [2] Lundbeck buys firm for Parkinson's drug
    Jarvis, Lisa
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (13) : 14 - 14
  • [3] LUNDBECK AND OTSUKA IN ALZHEIMER'S PACT
    不详
    CHEMICAL & ENGINEERING NEWS, 2013, 91 (13) : 19 - 19
  • [4] GSK buys rights to HIV drug
    不详
    CHEMISTRY WORLD, 2009, 6 (04): : 18 - 18
  • [5] Medeva buys RPR drug rights
    不详
    CHEMISTRY IN BRITAIN, 1996, 32 (07) : 11 - 11
  • [6] ALCON BUYS INTO EYE DISEASE DRUG
    不详
    CHEMICAL & ENGINEERING NEWS, 2012, 90 (13) : 27 - 27
  • [7] THE ROLE OF EPIDEMIOLOGY IN UNDERSTANDING ALZHEMIER'S DISEASE: THE MEANING OF "RISK"
    Ganguli, Mary
    INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 38TH SESSION, 2008, : 341 - 353
  • [8] The “rights” of precision drug development for Alzheimer’s disease
    Jeffrey Cummings
    Howard H. Feldman
    Philip Scheltens
    Alzheimer's Research & Therapy, 11
  • [9] The "rights" of precision drug development for Alzheimer's disease
    Cummings, Jeffrey
    Feldman, Howard H.
    Scheltens, Philip
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
  • [10] Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder
    Lin, Herng-Ching
    Xirasagar, Sudha
    Lee, Hsin-Chien
    Huang, Chung-Chien
    Chen, Chao-Hung
    PLOS ONE, 2017, 12 (06):
12345